Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers SARS-CoV-2 antibody test strips; blood glucose monitors; bi-functional blood glucose monitors; point of care testing products; digital management tool solutions; non-invasive screening products; diabetes peripheral products; and PTS and Trividia Products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to approximately 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People’s Republic of China.
Metrics to compare | 300298 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300298PeersSector | |
---|---|---|---|---|
P/E Ratio | 59.0x | 28.4x | −0.6x | |
PEG Ratio | −1.41 | −0.81 | 0.00 | |
Price/Book | 4.1x | 1.8x | 2.6x | |
Price / LTM Sales | 3.1x | 3.8x | 3.1x | |
Upside (Analyst Target) | 33.0% | 43.8% | 51.5% | |
Fair Value Upside | Unlock | 12.0% | 8.4% | Unlock |